SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-113973
Filing Date
2024-11-04
Accepted
2024-11-04 18:00:52
Documents
2
Group Members
MARK ANGELOSC-SIGMA GLOBAL PARTNERS, LPYA GLOBAL INVESTMENTS II (U.S.), LPYAII GP II, LLCYAII GP, LPYORKVILLE ADVISORS GLOBAL II, LLCYORKVILLE ADVISORS GLOBAL, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2427411d7_sc13ga.htm SC 13G/A 109008
2 EXHIBIT 99.1 tm2427420d1_ex99-1.htm EX-99.1 9886
  Complete submission text file 0001104659-24-113973.txt   121025
Mailing Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302
Business Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302 201 985 8300
YA II PN, Ltd. (Filed by) CIK: 0001463928 (see all company filings)

IRS No.: 980615492 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Subject) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: SC 13G/A | Act: 34 | File No.: 005-89881 | Film No.: 241424997
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)